• PDR Search

    Required field
  • Advertisement
  • FDA Date: 06/27/2017

    Thalomid (thalidomide) Capsules REMS

    Goals of the Thalomid (thalidomide) Capsules REMS Program

    The goals of the THALOMID risk evaluation and mitigation strategy are as follows:

    • To prevent the risk of embryo-fetal exposure to THALOMID.

    • To inform prescribers, patients, and pharmacists on the serious risks and safe-use conditions for THALOMID.

    REMS Elements

    • Elements to Assure Safe Use

    • Implementation System